Clinical Trial Site

Vienna 1210

4 studies enrolling now · 9 studies all time

What they study most

Atypical Hemolytic Uremic Syndrome (aHUS), Generalized Myasthenia Gravis, High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, Surgery, Transthyretin Amyloidosis (ATTR) With Cardiomyopathy, Transthyretin Amyloidosis With Cardiomyopathy, Wilson Disease

Studies at this site

• TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Recruiting now
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs) — Recruiting now
• A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Enrolling by invitation
• HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Running, not enrolling
• Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS) — Completed
• Trial of Andexanet in Patients Receiving an Oral FXa Inhibitor Who Require Urgent Surgery — Stopped early
• Efficacy and Safety Study of WTX101 (ALXN1840) in Adult Wilson Disease Patients — Completed
• The Assessment of Copper Parameters in Wilson Disease Participants on Standard of Care Treatment — Completed